Companies: 10,795·Total market cap: $144.5T
Q BioMed Inc.

Q BioMed Inc.

QBIOOTCHealthcare
$0.00
$-0.00(-0.00%)
Market Cap$14509
P/E Ratio—
52W High$0.02505
52W Low$0.000099999997
SEC Filings

Q BioMed Inc. (QBIO) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001596062 · QBIO · OTC · as of Jun 10, 2026

Filing snapshot

215
Total Filings
REVOKED
Latest Form
2026-04-02
Most Recent
2015
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001596062 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2023-05-26
Fiscal Year End
May 26, 2023
Accession No.
0001410578-23-001376
Primary Document
tmb-20221130x10k.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001596062 · Accession 0001410578-23-001376

Latest Key Filings

10-Q/AQuarterly Report
10-Q/A
2023-06-23
View 10-Q on SEC
8-KCurrent Report
FORM 8-K
2023-06-16Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
REVOKEDREVOKED
REVOKED
2026-04-02
View
SC 13G/ABeneficial Ownership Report (Amended)
SC 13G/A
2024-11-04
View
UPLOADUPLOAD
UPLOAD
2023-09-07
View
UPLOADUPLOAD
UPLOAD
2023-08-10
View
UPLOADUPLOAD
UPLOAD
2023-07-03
View
10-Q/AQuarterly Report (Amended)
10-Q/A
2023-06-23
View
8-KCurrent Report
FORM 8-K
2023-06-16
View
10-QQuarterly Report
10-Q
2023-06-16
View
8-KCurrent Report
FORM 8-K
2023-05-26
View
10-KAnnual Report
10-K
2023-05-26
View
NT 10-KNT 10-K
NT 10-K
2023-03-01
View
SC 13G/ABeneficial Ownership Report (Amended)
SC 13G/A
2023-01-03
View
DEF 14CDEF 14C
DEF 14C
2022-12-07
View
8-KCurrent Report
FORM 8-K
2022-11-18
View
PRE 14CPRE 14C
PRE 14C
2022-11-18
View
Showing 1–15 of 179 filingsForm 4 / 144 hidden· 215 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001596062  |  Exchange: OTC · Healthcare

Q BioMed Inc. (OTC: QBIO) has submitted 215 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001596062, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Q BioMed Inc.'s most comprehensive regulatory disclosure. The most recent Q BioMed Inc. 10-K was filed on 2023-05-26 for fiscal year ending 2023. Historical QBIO 10-K annual reports are available from 2014 through 2023.

Investors researching Q BioMed Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-10
Related Companies SEC Filings — Healthcare
OZYMF SEC Filings →PXMD SEC Filings →VAXX SEC Filings →SCPS SEC Filings →RGIN SEC Filings →VOQP SEC Filings →NNLX SEC Filings →RCAR SEC Filings →
→ QBIO Financials→ QBIO Earnings→ QBIO Insider Trades

Frequently Asked Questions

QBIO SEC Filings · 8 questions

Q BioMed Inc. (QBIO) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 215 filings and access original documents at no cost. Q BioMed Inc.'s CIK is 0001596062.

QBIO SEC filingsQ BioMed Inc. SEC documentsfind QBIO 10-K